Trials / Completed
CompletedNCT02973971
ADDIA Chronobiological Study
Pilot Study on Patients with Mild to Moderate Form of Alzheimer's Disease and Healthy Volunteers: Characterization of Intra-subject Variability and Chronobiological Variations of ADDIA Biomarkers.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Amoneta Diagnostics SAS · Industry
- Sex
- All
- Age
- 55 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The present single center clinical chronobiological study on 24 subjects (12 patients with mild to moderate form of Alzheimer's disease and 12 Healthy subjects) aims at characterizing the ADDIA biomarkers: a) blood cell-based biomarkers measured by flow cytometry using proprietary probes specific of two targeted biomarkers, beta-Amyloid (Aβ) peptide and a kinase, and b) circulating biomarkers in peripheral body fluids. The biomarkers will be analyzed on samples taken at different time points of the day, including under fasting and non-fasting conditions and at two periods: day 1 and day 14.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | volumeric MRI |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-03-29
- Completion
- 2018-03-29
- First posted
- 2016-11-28
- Last updated
- 2024-09-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02973971. Inclusion in this directory is not an endorsement.